This project explores the role of SMG1 on the Nonsense-mediated decay (NMD) pathway in two human cell lines – PC9 (lung) and A375 (epithelial). The conditions used were a DMSO control for two SMG1 inhibitors, and an siRNA control for the siSMG1 RNA knock-down condition.